South Shore Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$464K Buy
387
+23
+6% +$23.5K 0.31% 75
2026
Q1
$334K Buy
364
+174
+92% +$176K 0.24% 91
2025
Q4
$204K Buy
+190
New +$182K 0.15% 130

Other funds holding LLY

South Shore Capital Advisors's LLY Position: Q2 2026 in Review

South Shore Capital Advisors increased its Eli Lilly (LLY) stake by 6.3% in Q2 2026, buying an estimated $23.5K and bringing the position to 387 shares worth $464K. The position accounts for 0.31% of the portfolio, ranked #75.

South Shore Capital Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • South Shore Capital Advisors held 387 shares of Eli Lilly worth $464K as of Q2 2026.
  • South Shore Capital Advisors bought 23 Eli Lilly shares in Q2 2026, an estimated $23.5K.
  • Eli Lilly made up 0.31% of South Shore Capital Advisors's portfolio in Q2 2026, its #75 holding.
  • South Shore Capital Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on South Shore Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.